Companion Diagnostic Market, Global Outlook and Forecast 2022-2028

April 2022 | 61 pages | ID: C6414309EF0CEN
Market Monitor Global

Abstracts

A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.

This report contains market size and forecasts of Companion Diagnostic in Global, including the following market information:

Global Companion Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Companion Diagnostic market was valued at 9075.3 million in 2021 and is projected to reach US$ 31360 million by 2028, at a CAGR of 19.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immunohistochemistry Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Companion Diagnostic include Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Merck, Agendia, Qiagen, Myriad Genetics and Advanced Cell Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Companion Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Companion Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Companion Diagnostic Market Segment Percentages, by Type, 2021 (%)

• Immunohistochemistry
• Molecular Diagnosis

Global Companion Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Companion Diagnostic Market Segment Percentages, by Application, 2021 (%)

• Oncology
• Cardiovascular
• Central Nervous System
• Virology
• Others

Global Companion Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Companion Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Companion Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Companion Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche Holdings
• Abbott Laboratories
• Thermo Fisher Scientific
• Agilent Technologies
• Merck
• Agendia
• Qiagen
• Myriad Genetics
• Advanced Cell Diagnostics
• Danaher
• Illumina, Inc

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Companion Diagnostic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Companion Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COMPANION DIAGNOSTIC OVERALL MARKET SIZE

2.1 Global Companion Diagnostic Market Size: 2021 VS 2028
2.2 Global Companion Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Companion Diagnostic Players in Global Market
3.2 Top Global Companion Diagnostic Companies Ranked by Revenue
3.3 Global Companion Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Companion Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Companion Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Companion Diagnostic Players in Global Market
  3.6.1 List of Global Tier 1 Companion Diagnostic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Companion Diagnostic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Companion Diagnostic Market Size Markets, 2021 & 2028
  4.1.2 Immunohistochemistry
  4.1.3 Molecular Diagnosis
4.2 By Type - Global Companion Diagnostic Revenue & Forecasts
  4.2.1 By Type - Global Companion Diagnostic Revenue, 2017-2022
  4.2.2 By Type - Global Companion Diagnostic Revenue, 2023-2028
  4.2.3 By Type - Global Companion Diagnostic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Companion Diagnostic Market Size, 2021 & 2028
  5.1.2 Oncology
  5.1.3 Cardiovascular
  5.1.4 Central Nervous System
  5.1.5 Virology
  5.1.6 Others
5.2 By Application - Global Companion Diagnostic Revenue & Forecasts
  5.2.1 By Application - Global Companion Diagnostic Revenue, 2017-2022
  5.2.2 By Application - Global Companion Diagnostic Revenue, 2023-2028
  5.2.3 By Application - Global Companion Diagnostic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Companion Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Companion Diagnostic Revenue & Forecasts
  6.2.1 By Region - Global Companion Diagnostic Revenue, 2017-2022
  6.2.2 By Region - Global Companion Diagnostic Revenue, 2023-2028
  6.2.3 By Region - Global Companion Diagnostic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Companion Diagnostic Revenue, 2017-2028
  6.3.2 US Companion Diagnostic Market Size, 2017-2028
  6.3.3 Canada Companion Diagnostic Market Size, 2017-2028
  6.3.4 Mexico Companion Diagnostic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Companion Diagnostic Revenue, 2017-2028
  6.4.2 Germany Companion Diagnostic Market Size, 2017-2028
  6.4.3 France Companion Diagnostic Market Size, 2017-2028
  6.4.4 U.K. Companion Diagnostic Market Size, 2017-2028
  6.4.5 Italy Companion Diagnostic Market Size, 2017-2028
  6.4.6 Russia Companion Diagnostic Market Size, 2017-2028
  6.4.7 Nordic Countries Companion Diagnostic Market Size, 2017-2028
  6.4.8 Benelux Companion Diagnostic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Companion Diagnostic Revenue, 2017-2028
  6.5.2 China Companion Diagnostic Market Size, 2017-2028
  6.5.3 Japan Companion Diagnostic Market Size, 2017-2028
  6.5.4 South Korea Companion Diagnostic Market Size, 2017-2028
  6.5.5 Southeast Asia Companion Diagnostic Market Size, 2017-2028
  6.5.6 India Companion Diagnostic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Companion Diagnostic Revenue, 2017-2028
  6.6.2 Brazil Companion Diagnostic Market Size, 2017-2028
  6.6.3 Argentina Companion Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Companion Diagnostic Revenue, 2017-2028
  6.7.2 Turkey Companion Diagnostic Market Size, 2017-2028
  6.7.3 Israel Companion Diagnostic Market Size, 2017-2028
  6.7.4 Saudi Arabia Companion Diagnostic Market Size, 2017-2028
  6.7.5 UAE Companion Diagnostic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche Holdings
  7.1.1 Roche Holdings Corporate Summary
  7.1.2 Roche Holdings Business Overview
  7.1.3 Roche Holdings Companion Diagnostic Major Product Offerings
  7.1.4 Roche Holdings Companion Diagnostic Revenue in Global Market (2017-2022)
  7.1.5 Roche Holdings Key News
7.2 Abbott Laboratories
  7.2.1 Abbott Laboratories Corporate Summary
  7.2.2 Abbott Laboratories Business Overview
  7.2.3 Abbott Laboratories Companion Diagnostic Major Product Offerings
  7.2.4 Abbott Laboratories Companion Diagnostic Revenue in Global Market (2017-2022)
  7.2.5 Abbott Laboratories Key News
7.3 Thermo Fisher Scientific
  7.3.1 Thermo Fisher Scientific Corporate Summary
  7.3.2 Thermo Fisher Scientific Business Overview
  7.3.3 Thermo Fisher Scientific Companion Diagnostic Major Product Offerings
  7.3.4 Thermo Fisher Scientific Companion Diagnostic Revenue in Global Market (2017-2022)
  7.3.5 Thermo Fisher Scientific Key News
7.4 Agilent Technologies
  7.4.1 Agilent Technologies Corporate Summary
  7.4.2 Agilent Technologies Business Overview
  7.4.3 Agilent Technologies Companion Diagnostic Major Product Offerings
  7.4.4 Agilent Technologies Companion Diagnostic Revenue in Global Market (2017-2022)
  7.4.5 Agilent Technologies Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Companion Diagnostic Major Product Offerings
  7.5.4 Merck Companion Diagnostic Revenue in Global Market (2017-2022)
  7.5.5 Merck Key News
7.6 Agendia
  7.6.1 Agendia Corporate Summary
  7.6.2 Agendia Business Overview
  7.6.3 Agendia Companion Diagnostic Major Product Offerings
  7.6.4 Agendia Companion Diagnostic Revenue in Global Market (2017-2022)
  7.6.5 Agendia Key News
7.7 Qiagen
  7.7.1 Qiagen Corporate Summary
  7.7.2 Qiagen Business Overview
  7.7.3 Qiagen Companion Diagnostic Major Product Offerings
  7.7.4 Qiagen Companion Diagnostic Revenue in Global Market (2017-2022)
  7.7.5 Qiagen Key News
7.8 Myriad Genetics
  7.8.1 Myriad Genetics Corporate Summary
  7.8.2 Myriad Genetics Business Overview
  7.8.3 Myriad Genetics Companion Diagnostic Major Product Offerings
  7.8.4 Myriad Genetics Companion Diagnostic Revenue in Global Market (2017-2022)
  7.8.5 Myriad Genetics Key News
7.9 Advanced Cell Diagnostics
  7.9.1 Advanced Cell Diagnostics Corporate Summary
  7.9.2 Advanced Cell Diagnostics Business Overview
  7.9.3 Advanced Cell Diagnostics Companion Diagnostic Major Product Offerings
  7.9.4 Advanced Cell Diagnostics Companion Diagnostic Revenue in Global Market (2017-2022)
  7.9.5 Advanced Cell Diagnostics Key News
7.10 Danaher
  7.10.1 Danaher Corporate Summary
  7.10.2 Danaher Business Overview
  7.10.3 Danaher Companion Diagnostic Major Product Offerings
  7.10.4 Danaher Companion Diagnostic Revenue in Global Market (2017-2022)
  7.10.5 Danaher Key News
7.11 Illumina, Inc
  7.11.1 Illumina, Inc Corporate Summary
  7.11.2 Illumina, Inc Business Overview
  7.11.3 Illumina, Inc Companion Diagnostic Major Product Offerings
  7.11.4 Illumina, Inc Companion Diagnostic Revenue in Global Market (2017-2022)
  7.11.5 Illumina, Inc Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Companion Diagnostic Market Opportunities & Trends in Global Market
Table 2. Companion Diagnostic Market Drivers in Global Market
Table 3. Companion Diagnostic Market Restraints in Global Market
Table 4. Key Players of Companion Diagnostic in Global Market
Table 5. Top Companion Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Companion Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Companion Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Companion Diagnostic Product Type
Table 9. List of Global Tier 1 Companion Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Companion Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Companion Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Companion Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Companion Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Companion Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Companion Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Companion Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Companion Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Companion Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Companion Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Companion Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Companion Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Companion Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Companion Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Companion Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Companion Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Companion Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Companion Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Companion Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Companion Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. Roche Holdings Corporate Summary
Table 31. Roche Holdings Companion Diagnostic Product Offerings
Table 32. Roche Holdings Companion Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Laboratories Corporate Summary
Table 34. Abbott Laboratories Companion Diagnostic Product Offerings
Table 35. Abbott Laboratories Companion Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific Companion Diagnostic Product Offerings
Table 38. Thermo Fisher Scientific Companion Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. Agilent Technologies Corporate Summary
Table 40. Agilent Technologies Companion Diagnostic Product Offerings
Table 41. Agilent Technologies Companion Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Companion Diagnostic Product Offerings
Table 44. Merck Companion Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. Agendia Corporate Summary
Table 46. Agendia Companion Diagnostic Product Offerings
Table 47. Agendia Companion Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Qiagen Corporate Summary
Table 49. Qiagen Companion Diagnostic Product Offerings
Table 50. Qiagen Companion Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. Myriad Genetics Corporate Summary
Table 52. Myriad Genetics Companion Diagnostic Product Offerings
Table 53. Myriad Genetics Companion Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. Advanced Cell Diagnostics Corporate Summary
Table 55. Advanced Cell Diagnostics Companion Diagnostic Product Offerings
Table 56. Advanced Cell Diagnostics Companion Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. Danaher Corporate Summary
Table 58. Danaher Companion Diagnostic Product Offerings
Table 59. Danaher Companion Diagnostic Revenue (US$, Mn), (2017-2022)
Table 60. Illumina, Inc Corporate Summary
Table 61. Illumina, Inc Companion Diagnostic Product Offerings
Table 62. Illumina, Inc Companion Diagnostic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Companion Diagnostic Segment by Type in 2021
Figure 2. Companion Diagnostic Segment by Application in 2021
Figure 3. Global Companion Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Companion Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Companion Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Companion Diagnostic Revenue in 2021
Figure 8. By Type - Global Companion Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Companion Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Companion Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Companion Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Companion Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Companion Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Companion Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Companion Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Companion Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Holdings Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Laboratories Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Agilent Technologies Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Agendia Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Qiagen Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Myriad Genetics Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Advanced Cell Diagnostics Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Danaher Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Illumina, Inc Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)